thiazoles has been researched along with Weight Gain in 121 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (12.40) | 18.2507 |
| 2000's | 58 (47.93) | 29.6817 |
| 2010's | 44 (36.36) | 24.3611 |
| 2020's | 4 (3.31) | 2.80 |
| Authors | Studies |
|---|---|
| Aldiss, P; Bloor, I; Boocock, DJ; Budge, H; Chavoshinejad, R; Ebling, FJP; Lewis, JE; Lupini, I; Miles, AK; Symonds, ME | 1 |
| Horikoshi, S; Ichinose, M; Miura, I; Suzuki, Y; Watanabe, K | 1 |
| Ayesa Arriola, R; Crespo Facorro, B; Gómez Revuelta, M; Ibáñez Alario, M; Juncal Ruiz, M; Mayoral-van Son, J; Ortiz-García de la Foz, V; Vázquez-Bourgon, J | 1 |
| Broadbent, M; Dobson, RJB; Dzahini, O; Govind, R; Ibrahim, ZM; Iqbal, E; Kim, CH; MacCabe, JH; Romero, A; Smith, T; Stewart, R; Werbeloff, N | 1 |
| Barber, S; Cipriani, A; Corsi, M; Olotu, U | 1 |
| Hetrick, SE; Loy, JH; Merry, SN; Stasiak, K | 1 |
| Bellavia, A; Centorrino, F; Fitzmaurice, G; Jackson, JW; Valeri, L | 1 |
| Brixner, DI; Ghate, SR; Hashibe, M; Joy, E; Porucznik, CA; Said, Q | 1 |
| Calabrese, JR; Gao, K; Karayal, ON; Kolluri, S; Pappadopulos, E | 1 |
| Chen, AP; Juang, YY; Lee, CP | 1 |
| Hong, JP; Kim, MS; Park, S; Yi, KK | 1 |
| Aida, SA; Hatim, A; Mohamed, Z; Reynolds, GP; Roffeei, SN; Said, MA; Zainal, NZ | 1 |
| Dai, G; Zhang, Y | 1 |
| Iwata, N; Kishi, T; Matsuda, Y | 1 |
| Beszlej, A; Bienkowski, P; Frydecka, D; Grzywacz, A; Mierzejewski, P; Samochowiec, A; Samochowiec, J; Trześniowska-Drukała, B; Tybura, P | 1 |
| Amado, JA; Ayesa-Arriola, R; Crespo-Facorro, B; Garcia-Unzueta, MT; Martínez García, O; Ortiz-Garcia de la Foz, V; Pérez-Iglesias, R; Suarez-Pinilla, P; Tabares-Seisdedos, R | 1 |
| Bates, AJ; Eder, P; Laven, RA | 1 |
| Brennan, MD; Ramsey, TL | 1 |
| Calabrese, JR; Citrome, L; Dell'Osso, B; Frye, MA; Ketter, TA; Miller, S | 1 |
| Freeman, R; Mogul, H; Nguyen, K | 1 |
| Bates, AJ; Chapple, F; Laven, RA; Weeks, DS | 1 |
| Baer, L; Bobo, WV; Curren, L; Fava, M; Mischoulon, D; Papakostas, GI; Shelton, RC | 1 |
| Bai, YH; Cai, M; Chen, YC; Guo, L; McAlonan, GM; Tan, QR; Wang, HH; Wang, HN; Wang, Y; Wu, WJ; Zhang, RG; Zhang, YH; Zhang, ZJ | 1 |
| Chang, KD | 1 |
| Bisaga, A; Danysz, W; Foltin, RW | 1 |
| Brennan, MP; Collins, JG; Harding, MJ; Horvath, TL; Sinusas, AJ | 1 |
| Bogers, JP; Starrenburg, FC | 1 |
| Allison, DB; Giller, E; Loebel, A; Parsons, B; Romano, S; Siu, C; Williams, K | 1 |
| Lavedan, C; Thompson, A; Volpi, S | 1 |
| Baik, JH; Choi, SY; Noh, JS; Yoon, S | 1 |
| Black, C; Chan, CC; Crane, S; Guay, J; Guiral, S; Huang, Z; Li, CS; Oballa, R; Ramtohul, YK; Xu, LJ; Zhang, L | 1 |
| Davis, JM; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Lobos, CA; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Harada, K; Irie, M; Kayama, Y; Kondo, Y; Matsuoka, N; Mihara, T; Ni, K; Shobo, M; Yamada, H | 1 |
| Bouvier, ML; Gaebel, W; Henning, U; Schmitt, A; von Wilmsdorff, M | 1 |
| Case, M; Conley, RR; Hoffmann, VP; Jacobson, JG; Stauffer, VL | 1 |
| Citrome, L | 2 |
| Dänicke, S; Döll, S; Höltershinken, M; Renner, L; Schwabe, A | 1 |
| Dadić-Hero, E; Grahovac, T; Knez, R; Kosec, T; Ružić, K; Sabljić, V | 1 |
| Dadić-Hero, E; Grahovac, T; Palijan, TZ; Petranović, D; Ružić, K; Sepić-Grahovac, D | 1 |
| Dadić-Hero, E; Grahovac, T; Ružić, K; Sabljić, V; Sepić-Grahovac, D | 1 |
| Costa, LB; Freire, RS; Guerrant, RL; Hoffman, PS; JohnBull, EA; Lima, AA; Oriá, RB; Reeves, JT; Roche, JK; Sevilleja, JE; Warren, CA | 1 |
| Andreotti, S; Gattaz, WF; Lima, FB; Passos-Bueno, MR; Sertié, AL; Sertié, RA; Suzuki, AM | 1 |
| Doubova, SV; Flores-Hernández, S; Mino-León, D; Reyes-Morales, H | 1 |
| Li, YM; Ou, JJ; Wu, RR; Zhao, JP | 1 |
| Alonso, M; Alonso-Gascón, M; Baixeras, E; Bermúdez-Silva, FJ; López-Ogalla, J; Martínez, A; Pavón, FJ; Pérez-Valero, V; Rivera, P; Rodríguez de Fonseca, F; Romero-Cuevas, M; Santamaría, G; Serrano, A; Suarez, J; Vida, M | 1 |
| Colditz, IG; Lee, C; Palladin, P; Paull, DR; Small, AH | 1 |
| Chen, BJ; Chen, CY; Chou, IP; Hsieh, YH; Li, YH; Wang, HT | 1 |
| Cho, YM; Jeong, SW; Jung, H; Kim, JH; Kwak, SN; Kwon, OJ; Lee, KW; Oh, JE | 1 |
| Correll, CU; De Hert, M; Detraux, J; Sweers, K; van Winkel, R; Yu, W | 1 |
| Coetzee, JF; Gehring, R; KuKanich, B; Mosher, RA; Reinbold, JB; Robert, B; White, BJ | 1 |
| Arndt, SS; Hellebrekers, LJ; Mitsogiannis, MD; Schaap, MW; Uilenreef, JJ; van 't Klooster, JG | 1 |
| Agid, O; Pappadopulos, E; Remington, G; Siu, CO; Vanderburg, D | 1 |
| Mohan, V; Vidhya, S | 1 |
| German, JB; Leiter, EH; Pan, HJ; Reifsnyder, PR; Watkins, SM | 1 |
| Asnani, S; Fonseca, VA; Gouda, BP | 1 |
| Cobitz, AR; Haimbach, RE; Jucker, BM; Mayer, ME; Ohlstein, DH; Sarkar, SK; Schaeffer, TR; Smith, SA | 1 |
| Kaye, NS | 1 |
| Camp, HS | 1 |
| Jensen, PB; Larsen, LK; Larsen, PJ; Sørensen, RV; Vrang, N; Wassermann, K; Wulff, EM | 1 |
| Cohen, SA; Fitzgerald, BJ; Khan, A; Khan, SR | 1 |
| Avery, MA; Benson, SC; Chittiboyina, A; Desai, P; Ho, CI; Kurtz, TW; Pershadsingh, HA; Pravenec, M; Qi, N; Wang, J | 1 |
| Nakamura, M; Nishida, M | 1 |
| Arnold, G; Meisel, A; Winter, C; Zschenderlein, R | 1 |
| Glick, ID; Romano, SJ; Simpson, GM; Siu, CO; Weiden, PJ | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Citrome, L; Volavka, J | 1 |
| Bobes, J; Cañas, F; Mackell, J; Rejas, J | 1 |
| Anderson, J; Bradbury, MJ; Campbell, U; Chapman, D; Cosford, ND; Giracello, D; King, C; Strack, AM; Tehrani, L; Varney, MA | 1 |
| Murray, S; Pigott, T; Romano, SJ; Simpson, GM; Siu, CO; Weiden, P | 1 |
| Davis, CE; Davis, SM; Hsiao, JK; Keefe, RS; Lebowitz, BD; Lieberman, JA; McEvoy, JP; Perkins, DO; Rosenheck, RA; Severe, J; Stroup, TS; Swartz, MS | 1 |
| Clemens, JA; Panetta, JA; Shaw, WN | 1 |
| Murray, S; Olié, JP; Spina, E; Yang, R | 1 |
| Kostulski, A; Rabe-Jabłońska, J; Wyszogrodzka-Kucharska, A | 1 |
| Jones, DN; Kalinichev, M; Rourke, C | 1 |
| Arch, JR; Birtles, S; de Schoolmeester, J; Hislop, D; Moody, G; O'Dowd, J; Smith, DM; Swales, J; Turnbull, AV; Wang, SJ | 1 |
| Adams, DH; Ascher-Svanum, H; Edwards, SB; Kinon, BJ; Lipkovich, I; Siris, SG | 1 |
| de Beaurepaire, R; Even, PC; Lacroix, M; Minet-Ringuet, J; Tomé, D | 1 |
| Carpéné, C; Daviaud, D; de Beaurepaire, R; Even, PC; Minet-Ringuet, J; Prévot, D; Quignard-Boulange, A; Tomé, D; Valet, P; Visentin, V | 1 |
| Granado, M; López-Calderón, A; Martín, AI; Villanúa, MA | 1 |
| Li, S; Li, W; Matsumoto, K; Tang, Y; Wang, C; Wang, M | 1 |
| Perlis, RH | 1 |
| Neill, JC; Reynolds, GP; Snigdha, S; Thumbi, C | 1 |
| Anjum, N; Fell, MJ; Marshall, KM; Neill, JC; Peltola, LM | 1 |
| Cater, JR; Delaney, MA; Hyman, SB; Malone, RP | 1 |
| Anderson, JA; Dostal, LA | 1 |
| Auld, PA; Frayer, WW; Jain, A; Madsen, DC; Mårtensson, J; Meister, A; Schwartz, MK | 1 |
| Bussi, R; Cavalletti, E; Ceserani, R; Montaguti, P; Tognella, S | 1 |
| Rusk, MH | 1 |
| Gorson, DM | 1 |
| Davies, R; Friedman, JH; Jacques, C | 1 |
| Igarashi, T; Toritsuka, N; Tsukidate, K | 1 |
| Allison, DB; Cappelleri, JC; Chandler, LP; Cheskin, LJ; Fontaine, KR; Heo, M; Mentore, JL; Weiden, PJ | 1 |
| Allison, DB; Cappelleri, JC; Chandler, LP; Heo, M; Infante, MC; Mentore, JL; Weiden, PJ | 1 |
| Brunmair, B; Fürnsinn, C; Furtmüller, R; Kühnle, HF; Meyer, M; Neschen, S; Nowotny, P; Roden, M; Schneider, B; Waldhäusl, W | 1 |
| Abe, H; Kusano, S | 1 |
| Hirayama, R; Kurosaki, E; Nakano, R; Shibasaki, M; Shikama, H; Shimaya, A | 1 |
| McAskill, R; Taylor, DM | 1 |
| Krische, D | 1 |
| Akazawa, S; Eguchi, K; Ito, M; Kawasaki, E; Sun, F | 1 |
| Boel, E; Christensen, M; Mortensen, SB; Oturai, PS; Pedersen, KE; Rolin, B | 1 |
| Larsen, PJ | 1 |
| Gruenewald, DA; Marck, BT; Matsumoto, AM; Naai, MA; Wolden-Hanson, T | 1 |
| Kenyon, CJ; Livingstone, DE; Walker, BR | 1 |
| Cawthorne, MA; Emilsson, V; Heyman, R; Liu, YL; O'Dowd, J; Sennitt, M; Wang, S | 1 |
| Casey, DE; Zorn, SH | 1 |
| Burkey, BF; Chen, W; de Souza, CJ; Dong, M; Eckhardt, M; Gagen, K; Laurent, D | 1 |
| Belcher, G; Hanefeld, M | 1 |
| Sussman, N | 1 |
| Isley, WL | 1 |
| Goodnick, PJ | 1 |
| Marck, BT; Matsumoto, AM; Wolden-Hanson, T | 1 |
| Caley, CF; Cooper, CK | 1 |
| Fukami, T; Fukuroda, T; Gomori, A; Hata, M; Hidaka, M; Ihara, M; Ishihara, A; Ishii, Y; Kanatani, A; Kanesaka, M; Kanno, T; Kobayashi, M; Mashiko, S; Murai, T; Okada, M; Sato, NA; Tanaka, T; Tominaga, Y; Watanabe, K | 1 |
| Scheen, A | 1 |
| Scheen, AJ | 1 |
| Baker, E; Jacobs, A; Peter, H; Wong, A | 1 |
| Fricke, RF; Jorge, J | 1 |
| Bleyl, DW; Kroh, L; Lewerenz, HJ; Macholz, R; Plass, R; Zeise, S | 1 |
| Baker, DH; Chung, TK; Funk, MA | 1 |
27 review(s) available for thiazoles and Weight Gain
| Article | Year |
|---|---|
Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy.
Topics: Antipsychotic Agents; Humans; Isoindoles; Lurasidone Hydrochloride; Schizophrenia; Serotonin; Thiazoles; Weight Gain | 2023 |
Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Clozapine; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2017 |
Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Conduct Disorder; Depressive Disorder, Major; Dibenzothiazepines; Humans; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Weight Gain | 2017 |
Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia.
Topics: Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Humans; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Sleep Stages; Thiazoles; Weight Gain | 2013 |
Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Blood Glucose; Double-Blind Method; Glycated Hemoglobin; Heart; Humans; Isoindoles; Piperazines; Piperidines; Randomized Controlled Trials as Topic; Risk; Schizophrenia; Thiazoles; Weight Gain | 2014 |
Balancing benefits and harms of treatments for acute bipolar depression.
Topics: Acute Disease; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Dibenzothiazepines; Drug Combinations; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lurasidone Hydrochloride; Multicenter Studies as Topic; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Thiazoles; Triazines; Weight Gain | 2014 |
The use of atypical antipsychotics in pediatric bipolar disorder.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Bipolar Disorder; Child; Comorbidity; Dibenzothiazepines; Disorders of Excessive Somnolence; Humans; Obesity; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Weight Gain | 2008 |
How can antipsychotics cause Diabetes Mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins.
Topics: Adiponectin; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Clozapine; Diabetes Mellitus; Humans; Leptin; Obesity; Olanzapine; Piperazines; Quinolones; Receptor, Muscarinic M3; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Receptors, Histamine; Serotonin 5-HT1 Receptor Agonists; Thiazoles; Weight Gain | 2009 |
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2010 |
Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic.
Topics: Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Disorders of Excessive Somnolence; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Isoindoles; Lurasidone Hydrochloride; Randomized Controlled Trials as Topic; Schizophrenia; Serotonin 5-HT2 Receptor Antagonists; Thiazoles; Treatment Outcome; United States; United States Food and Drug Administration; Weight Gain | 2011 |
Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
Topics: Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Isoindoles; Isoxazoles; Lipid Metabolism; Lurasidone Hydrochloride; Paliperidone Palmitate; Piperidines; Pyrimidines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Weight Gain | 2012 |
Effects of thiazolidinediones on cardiovascular risk factors.
Topics: Arteriosclerosis; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Fibrinolysis; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Insulin Resistance; Risk Factors; Thiazoles; Vascular Resistance; Weight Gain | 2002 |
Thiazolidinediones in diabetes: current status and future outlook.
Topics: Animals; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Humans; Hypoglycemic Agents; Lipids; Thiazoles; Weight Gain | 2003 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain | 2004 |
[Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
Topics: Antipsychotic Agents; Body Weight; Clozapine; Dibenzothiazepines; Humans; Hyperlipidemias; Leptin; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles; Weight Gain | 2005 |
Treatment of bipolar disorder: the evolving role of atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Arrhythmias, Cardiac; Benzodiazepines; Bipolar Disorder; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Humans; Hyperprolactinemia; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome; Weight Gain | 2007 |
Antipsychotic-induced weight gain: a comprehensive research synthesis.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Confidence Intervals; Drug Administration Schedule; Humans; Molindone; Piperazines; Placebos; Psychotic Disorders; Research Design; Thiazoles; Treatment Outcome; Weight Gain | 1999 |
Atypical antipsychotics and weight gain--a systematic review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles; Weight Gain | 2000 |
The glitazones: proceed with caution.
Topics: Chromans; Diabetes Mellitus, Type 2; Drug Evaluation; Humans; Hypoglycemic Agents; Liver; Pioglitazone; Prognosis; Rosiglitazone; Safety; Thiazoles; Thiazolidinediones; Troglitazone; Weight Gain | 2000 |
The pharmacology of weight gain with antipsychotics.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Eating; Humans; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Rats; Receptors, Neurotransmitter; Schizophrenia; Thiazoles; Weight Gain | 2001 |
Safety profile of pioglitazone.
Topics: Cardiovascular System; Edema; Humans; Hypoglycemic Agents; Pioglitazone; Randomized Controlled Trials as Topic; Thiazoles; Thiazolidinediones; Weight Gain | 2001 |
Review of atypical antipsychotics and weight gain.
Topics: Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Hospitalization; Humans; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Research Design; Schizophrenia; Thiazoles; Weight Gain | 2001 |
Ziprasidone: profile on safety.
Topics: Antipsychotic Agents; Blood Glucose; Electrocardiography; Humans; Lipids; Piperazines; Prolactin; Psychotic Disorders; Thiazoles; Weight Gain | 2001 |
Ziprasidone: the fifth atypical antipsychotic.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Body Weight; Headache; Humans; Injections, Intramuscular; Long QT Syndrome; Nausea; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain | 2002 |
[Glitazones and weight gain].
Topics: Adipose Tissue; Blood Glucose; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin Resistance; Risk Factors; Thiazoles; Thiazolidinediones; Weight Gain | 2002 |
[Medication of the month. Rosiglitazone (Avandia)].
Topics: Administration, Oral; Diabetes Mellitus, Type 2; Heart Failure; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; Prognosis; Risk Factors; Rosiglitazone; Thiazoles; Thiazolidinediones; Weight Gain | 2002 |
31 trial(s) available for thiazoles and Weight Gain
| Article | Year |
|---|---|
A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Energy Metabolism; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Time Factors; Weight Gain; Young Adult | 2020 |
The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial.
Topics: Adult; Antipsychotic Agents; Body-Weight Trajectory; Female; Humans; Male; Middle Aged; Olanzapine; Perphenazine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain | 2019 |
Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Appetite; Benzodiazepines; Body Composition; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Energy Metabolism; Female; Humans; Male; Middle Aged; Olanzapine; Pilot Projects; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Weight Gain; Young Adult | 2013 |
Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone.
Topics: Adult; Alleles; Antipsychotic Agents; Aripiprazole; Body Mass Index; Female; Follow-Up Studies; Genotype; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Piperazines; Polymorphism, Genetic; Quinolones; Receptors, Adrenergic, alpha-2; Schizophrenia; Thiazoles; Weight Gain; Weight Loss | 2014 |
Efficacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Body Mass Index; China; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Hyperglycemia; Hyperlipidemias; Isoxazoles; Male; Metabolic Diseases; Paliperidone Palmitate; Piperazines; Psychiatric Status Rating Scales; Pyrimidines; Quinolones; Schizophrenia; Thiazoles; Weight Gain; Young Adult | 2012 |
Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Catechol O-Methyltransferase; Dopamine Plasma Membrane Transport Proteins; Female; Genotype; GluK3 Kainate Receptor; Humans; Male; Middle Aged; Monoamine Oxidase; Olanzapine; Overweight; Perazine; Piperazines; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Kainic Acid; Schizophrenia, Paranoid; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Weight Gain; Young Adult | 2014 |
Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Cholesterol; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Piperazines; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Sex Factors; Thiazoles; Weight Gain | 2014 |
Effect of analgesia and anti-inflammatory treatment on weight gain and milk intake of dairy calves after disbudding.
Topics: Analgesia; Anesthetics, Local; Animal Husbandry; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Eating; Horns; Hypnotics and Sedatives; Lidocaine; Meloxicam; Pain; Thiazines; Thiazoles; Weight Gain; Xylazine | 2015 |
Glucagon-like peptide 1 receptor (GLP1R) haplotypes correlate with altered response to multiple antipsychotics in the CATIE trial.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers, Pharmacological; Dibenzothiazepines; Female; Genotyping Techniques; Glucagon-Like Peptide-1 Receptor; Haplotypes; Humans; Male; Models, Genetic; Olanzapine; Perphenazine; Piperazines; Polymorphism, Single Nucleotide; Quetiapine Fumarate; Receptors, Glucagon; Regression Analysis; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain; White People | 2014 |
METFORMIN-SUSTAINED WEIGHT LOSS AND REDUCED ANDROID FAT TISSUE AT 12 MONTHS IN EMPOWIR (ENHANCE THE METABOLIC PROFILE OF WOMEN WITH INSULIN RESISTANCE): A DOUBLE BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF NORMOGLYCEMIC WOMEN WITH MIDLIFE WEIGHT GAIN.
Topics: Adipose Tissue; Adult; Aging; Body Fat Distribution; Climacteric; Double-Blind Method; Drug Combinations; Female; Humans; Insulin Resistance; Metformin; Middle Aged; Obesity; Overweight; Placebos; Thiazoles; Weight Gain; Weight Loss | 2016 |
The effect of different combinations of local anaesthesia, sedative and non-steroidal anti-inflammatory drugs on daily growth rates of dairy calves after disbudding.
Topics: Anesthesia, Local; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Conscious Sedation; Dairying; Female; Horns; Hypnotics and Sedatives; Ketoprofen; Meloxicam; Thiazines; Thiazoles; Weight Gain; Xylazine | 2016 |
Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Electrocardiography; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Selective Serotonin Reuptake Inhibitors; Thiazoles; Weight Gain; Young Adult | 2017 |
An assessor-blinded, randomized comparison of efficacy and tolerability of switching from olanzapine to ziprasidone and the combination of both in schizophrenia spectrum disorders.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Drug Substitution; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Metabolic Syndrome; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Single-Blind Method; Thiazoles; Treatment Outcome; Weight Gain | 2017 |
Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.
Topics: Analysis of Variance; Antipsychotic Agents; Female; Follow-Up Studies; Gene Frequency; Genotype; Humans; Isoxazoles; Male; Piperazines; Piperidines; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2C; Schizophrenia; Thiazoles; Weight Gain | 2010 |
Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controll
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Drug Monitoring; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Quinolones; Schizophrenia; Thiazoles; Time Factors; Triglycerides; Weight Gain | 2010 |
Efficacy and tolerability of ziprasidone vs. olanzapine in naive first-episode schizophrenia: a 6-week, randomized, open-label, flexible-dose study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comparative Effectiveness Research; Dose-Response Relationship, Drug; Drug Monitoring; Episode of Care; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; Weight Gain | 2012 |
Evaluating a novel analgesic strategy for ring castration of ram lambs.
Topics: Analgesics; Animals; Behavior, Animal; Body Temperature; Clonixin; Drug Administration Schedule; Hydrocortisone; Male; Meloxicam; Orchiectomy; Pain; Sheep; Sheep Diseases; Thiazines; Thiazoles; Weight Gain | 2012 |
Albusin B modulates lipid metabolism and increases antioxidant defense in broiler chickens by a proteomic approach.
Topics: Animals; Antioxidants; ATP-Binding Cassette Transporters; Bacteriocins; Chickens; Diet; Dietary Supplements; Down-Regulation; Enzyme Induction; Fatty Acid-Binding Proteins; Female; Gene Expression Profiling; Hydroxymethylglutaryl CoA Reductases; Hypolipidemic Agents; Jejunum; Lipid Metabolism; Liver; Male; Recombinant Proteins; Superoxide Dismutase; Superoxide Dismutase-1; Thiazoles; Weight Gain | 2013 |
Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Cholesterol; Dibenzothiazepines; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Isoindoles; Likelihood Functions; Lurasidone Hydrochloride; Male; Medication Adherence; Nausea; Numbers Needed To Treat; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Research Design; Schizophrenia; Thiazoles; Treatment Outcome; Triglycerides; Weight Gain | 2012 |
Pharmacokinetics and effect of intravenous meloxicam in weaned Holstein calves following scoop dehorning without local anesthesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Cattle Diseases; Heart Rate; Horns; Hydrocortisone; Meloxicam; Pain; Substance P; Thiazines; Thiazoles; Weight Gain | 2012 |
Optimizing the dosing interval of buprenorphine in a multimodal postoperative analgesic strategy in the rat: minimizing side-effects without affecting weight gain and food intake.
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Buprenorphine; Drug Therapy, Combination; Electrodes, Implanted; Feeding Behavior; Injections, Subcutaneous; Male; Meloxicam; Neurosurgical Procedures; Pain, Postoperative; Pica; Postoperative Care; Rats; Rats, Wistar; Thiazines; Thiazoles; Time Factors; Weight Gain | 2012 |
Early prediction of clinical and functional outcome in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition; Cognition Disorders; Double-Blind Method; Drug Monitoring; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Models, Biological; Olanzapine; Patient Dropouts; Piperazines; Prognosis; Psychiatric Status Rating Scales; Schizophrenia; Thiazoles; Weight Gain | 2013 |
Ziprasidone augmentation of clozapine in 11 patients.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain | 2003 |
The effect of a switch to ziprasidone in an adult population with autistic disorder: chart review of naturalistic, open-label treatment.
Topics: Adult; Age Factors; Antipsychotic Agents; Autistic Disorder; Cholesterol; Female; Humans; Male; Middle Aged; Piperazines; Retrospective Studies; Thiazoles; Treatment Outcome; Weight Gain | 2004 |
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome; Weight Gain | 2004 |
Economic consequences of the adverse reactions related with antipsychotics: an economic model comparing tolerability of ziprasidone, olanzapine, risperidone, and haloperidol in Spain.
Topics: Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dyskinesia, Drug-Induced; Follow-Up Studies; Haloperidol; Hospitalization; Humans; Mental Disorders; Models, Econometric; Olanzapine; Outpatients; Patient Compliance; Piperazines; Psychiatric Status Rating Scales; Retrospective Studies; Risperidone; Sensitivity and Specificity; Spain; Survival Analysis; Thiazoles; Treatment Outcome; Weight Gain | 2004 |
Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia.
Topics: Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Obesity; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome; Weight Gain | 2005 |
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dibenzothiazepines; Double-Blind Method; Female; Humans; Lipids; Male; Olanzapine; Patient Compliance; Perphenazine; Piperazines; Proportional Hazards Models; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Weight Gain | 2005 |
Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Behavioral Symptoms; Double-Blind Method; Female; Hospitalization; Humans; Ketones; Male; Middle Aged; Movement Disorders; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Treatment Outcome; Weight Gain; Weight Loss | 2006 |
A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms.
Topics: Antipsychotic Agents; Benzodiazepines; Depression; Glycated Hemoglobin; Humans; Olanzapine; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Triglycerides; United States; Weight Gain | 2006 |
Efficacy of troglitazone on body fat distribution in type 2 diabetes.
Topics: Adipose Tissue; Body Mass Index; C-Peptide; Chromans; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Sex Characteristics; Thiazoles; Thiazolidinediones; Tomography, X-Ray Computed; Troglitazone; Viscera; Weight Gain | 2000 |
63 other study(ies) available for thiazoles and Weight Gain
| Article | Year |
|---|---|
Cold Exposure Drives Weight Gain and Adiposity following Chronic Suppression of Brown Adipose Tissue.
Topics: Acetanilides; Adipose Tissue, Brown; Animals; Cold Temperature; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation; Male; Proteomics; Rats; Subcutaneous Fat; Thermogenesis; Thiazoles; Uncoupling Protein 1; Weight Gain | 2022 |
The side effect profile of Clozapine in real world data of three large mental health hospitals.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Databases, Factual; Female; Hospitals, Psychiatric; Humans; Infant; Male; Middle Aged; Olanzapine; Piperazines; Risperidone; Schizophrenia; Thiazoles; Weight Gain | 2020 |
Association between second-generation antipsychotics and changes in body mass index in adolescents.
Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Confidence Intervals; Dibenzothiazepines; Female; Humans; Male; Medical Audit; Olanzapine; Piperazines; Quetiapine Fumarate; Regression Analysis; Retrospective Studies; Risperidone; Thiazoles; United States; Weight Gain | 2013 |
Weight Gain While Switching from Polypharmacy to Ziprasidone: A Case Report.
Topics: Adult; Antipsychotic Agents; Female; Humans; Metabolic Syndrome; Piperazines; Polypharmacy; Schizophrenia, Paranoid; Thiazoles; Weight Gain | 2015 |
Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder.
Topics: Animals; Appetite; Bulimia Nervosa; Candy; Conditioning, Operant; Consummatory Behavior; Dexfenfluramine; Dose-Response Relationship, Drug; Eating; Excitatory Amino Acid Antagonists; Female; Male; Memantine; Papio cynocephalus; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Reinforcement Schedule; Serotonin Receptor Agonists; Sex Characteristics; Thiazoles; Weight Gain | 2008 |
Correlation between body weight changes and postoperative pain in rats treated with meloxicam or buprenorphine.
Topics: Analgesia; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Buprenorphine; Intubation, Intratracheal; Meloxicam; Pain, Postoperative; Rats; Rats, Inbred Lew; Thiazines; Thiazoles; Thoracotomy; Weight Gain | 2009 |
Weight effects associated with antipsychotics: a comprehensive database analysis.
Topics: Antipsychotic Agents; Databases, Bibliographic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Piperazines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Time Factors; Weight Gain | 2009 |
Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Eating; Male; Mice; Mice, Knockout; Motor Activity; Olanzapine; Piperazines; Receptors, Dopamine D2; Risperidone; Thiazoles; Weight Gain | 2010 |
SAR and optimization of thiazole analogs as potent stearoyl-CoA desaturase inhibitors.
Topics: Administration, Oral; Animals; Dietary Fats; Enzyme Inhibitors; Hep G2 Cells; Humans; Hypoglycemic Agents; Mice; Mice, Inbred C57BL; Oxadiazoles; Stearoyl-CoA Desaturase; Structure-Activity Relationship; Thiazoles; Weight Gain | 2010 |
Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Feeding Behavior; Hyperphagia; Male; Olanzapine; Piperazines; Rats; Rats, Sprague-Dawley; Thiazoles; Weight Gain | 2011 |
The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats.
Topics: Animals; Antipsychotic Agents; Blotting, Western; Clozapine; Eating; Exploratory Behavior; Haloperidol; Hypothalamus; Leptin; Male; Motor Activity; Piperazines; Rats; Rats, Wistar; Receptors, Leptin; Thiazoles; Time Factors; Weight Gain | 2010 |
Effect of rare earth elements on beef cattle growth performance, blood clinical chemical parameters and mitogen stimulated proliferation of bovine peripheral blood mononuclear cells in vitro and ex vivo.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Blood Chemical Analysis; Body Weight; Cattle; Cell Proliferation; Cell Separation; Coloring Agents; Growth; In Vitro Techniques; Male; Metals, Rare Earth; Mitogens; Monocytes; Tetrazolium Salts; Thiazoles; Weight Gain | 2011 |
Switching among antipsychotics--focus on side effects.
Topics: Affective Disorders, Psychotic; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Eruptions; Drug Substitution; Drug Therapy, Combination; Female; Humans; Middle Aged; Olanzapine; Piperazines; Pruritus; Sulpiride; Thiazoles; Weight Gain | 2011 |
Antipsychotic treatment--side-effect and/or metabolic syndrome.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Combined Modality Therapy; Drug Substitution; Female; Humans; Metabolic Syndrome; Olanzapine; Piperazines; Psychotherapy; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thiazoles; Weight Gain | 2011 |
Weight gain--as possible predictor of metabolic syndrome.
Topics: Adult; Antipsychotic Agents; Body Mass Index; Dibenzothiazepines; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Metabolic Syndrome; Patient Admission; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Thiazoles; Weight Gain | 2011 |
Cryptosporidium-malnutrition interactions: mucosal disruption, cytokines, and TLR signaling in a weaned murine model.
Topics: Animals; Antiparasitic Agents; Cryptosporidiosis; Cryptosporidium parvum; Cytokines; Disease Models, Animal; DNA, Protozoan; Feces; Female; Ileum; Intestinal Mucosa; Malnutrition; Mice; Mice, Inbred C57BL; Nitro Compounds; RNA, Messenger; Thiazoles; Toll-Like Receptors; Weaning; Weight Gain | 2011 |
Effects of antipsychotics with different weight gain liabilities on human in vitro models of adipose tissue differentiation and metabolism.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Haloperidol; Humans; Olanzapine; Piperazines; Thiazoles; Weight Gain | 2011 |
Postmarketing pharmacovigilance of adverse drug reactions: the case of rosiglitazone in Mexico.
Topics: Administration, Oral; Adult; Aged; Diabetes Mellitus, Type 2; Drug Combinations; Edema; Female; Follow-Up Studies; Glyburide; Humans; Hypoglycemic Agents; Male; Medication Adherence; Metformin; Mexico; Middle Aged; Pharmacovigilance; Prospective Studies; Rosiglitazone; Thiazoles; Thiazolidinediones; Weight Gain | 2012 |
Adiponectin promoter activator NP-1 reduces body weight and hepatic steatosis in high-fat diet-fed animals.
Topics: Adiponectin; Analysis of Variance; Animals; Avoidance Learning; Blotting, Western; Body Weight; Cell Line; Diet, High-Fat; Dietary Fats; Eating; Fatty Liver; Glucose Tolerance Test; Lipid Metabolism; Liver; Male; Myoblasts; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; RNA; Taste; Thiazoles; Weight Gain | 2012 |
Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics.
Topics: Adipocytes, Brown; Adipogenesis; Adipokines; Animals; Antipsychotic Agents; Cell Differentiation; Cell Line; Cell Survival; Clozapine; Dibenzothiazepines; Gene Expression Regulation; Humans; Mice; Piperazines; Quetiapine Fumarate; Schizophrenia; Thiazoles; Weight Gain | 2012 |
Rosiglitazone--useful drug but has side effects.
Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Lipids; Rosiglitazone; Thiazoles; Thiazolidinediones; Weight Gain | 2002 |
Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone.
Topics: Adipose Tissue; Animals; Diabetes Mellitus, Type 2; Gene Expression; Heart; Lipid Metabolism; Lipids; Liver; Male; Mice; Mice, Obese; Myocardium; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Weight Gain | 2002 |
Reduction of intramyocellular lipid following short-term rosiglitazone treatment in Zucker fatty rats: an in vivo nuclear magnetic resonance study.
Topics: Animals; Blood Glucose; Insulin; Lipid Metabolism; Lipids; Magnetic Resonance Spectroscopy; Muscle Fibers, Skeletal; Muscle, Skeletal; Obesity; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides; Weight Gain | 2003 |
Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis.
Topics: Adipose Tissue; Animals; Biomarkers; Blood Glucose; Eating; Energy Metabolism; Fenofibrate; Gene Expression; Glucose Tolerance Test; Glycated Hemoglobin; Homeostasis; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Lipids; Liver; Male; Obesity; Organ Size; Oxazines; Phenylpropionates; Pioglitazone; Rats; Rats, Mutant Strains; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors; Weight Gain | 2003 |
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.
Topics: Adipocytes; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Cell Differentiation; Cells, Cultured; Chlorocebus aethiops; Drug Evaluation, Preclinical; Gene Expression Regulation; Imidazoles; Insulin; Irbesartan; Losartan; Male; Mice; Models, Molecular; Myoblasts; Protein Conformation; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Structure-Activity Relationship; Telmisartan; Tetrazoles; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Triglycerides; Valine; Valsartan; Weight Gain | 2004 |
Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia: three case reports.
Topics: Adult; Antipsychotic Agents; Diabetes Mellitus, Type 2; Humans; Indoles; Isoindoles; Male; Middle Aged; Obesity; Schizophrenia; Thiazoles; Weight Gain | 2004 |
Tourette syndrome: efficient treatment with ziprasidone and normalization of body weight in a patient with excessive weight gain under tiapride.
Topics: Adult; Antipsychotic Agents; Body Weight; Female; Humans; Obesity; Piperazines; Thiazoles; Tiapamil Hydrochloride; Tourette Syndrome; Weight Gain | 2004 |
Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice.
Topics: Animals; Appetite; Appetite Depressants; Dietary Fats; Eating; Energy Metabolism; Fenfluramine; Food Deprivation; Male; Mice; Mice, Knockout; Obesity; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Reward; Thiazoles; Weight Gain | 2005 |
LY226936 administered orally and centrally to obese Zucker rats suppresses food intake and body weight gain.
Topics: Administration, Oral; Animals; Appetite Depressants; Dose-Response Relationship, Drug; Eating; Female; Injections, Intraventricular; Male; Obesity; Random Allocation; Rats; Rats, Zucker; Specific Pathogen-Free Organisms; Thiazoles; Weight Gain | 1994 |
Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Female; Olanzapine; Piperazines; Prolactin; Rats; Rats, Sprague-Dawley; Thiazoles; Weight Gain | 2006 |
Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Blood Glucose; Body Weight; Diet; Diet, Reducing; Energy Intake; Energy Metabolism; Enzyme Inhibitors; Female; Insulin; Kinetics; Mice; Mice, Inbred C57BL; Obesity; Piperazines; Sulfonamides; Thiazoles; Weight Gain | 2006 |
A model for antipsychotic-induced obesity in the male rat.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Body Composition; Body Weight; Circadian Rhythm; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Haloperidol; Male; Obesity; Olanzapine; Piperazines; Rats; Rats, Sprague-Dawley; Thiazoles; Time Factors; Weight Gain | 2006 |
Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment.
Topics: Adipocytes; Animals; Antipsychotic Agents; Benzodiazepines; Cell Size; Drug Administration Schedule; Fatty Acid Synthases; Gene Expression Regulation; Glucose Transport Proteins, Facilitative; Haloperidol; Lipid Metabolism; Male; Obesity; Olanzapine; Piperazines; Rats; Rats, Sprague-Dawley; RNA; Statistics, Nonparametric; Sterol Esterase; Thiazoles; Weight Gain | 2007 |
Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.
Topics: Animals; Arthritis, Experimental; Cachexia; Chronic Disease; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Activation; Gene Expression; Growth Hormone; Indomethacin; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor I; Liver; Male; Meloxicam; Muscle Proteins; Muscle, Skeletal; Pituitary Gland; Rats; Rats, Wistar; RNA, Messenger; SKP Cullin F-Box Protein Ligases; Thiazines; Thiazoles; Tripartite Motif Proteins; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases; Weight Gain | 2007 |
Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms.
Topics: Alkaloids; Animals; Antidepressive Agents; Benzodioxoles; Brain-Derived Neurotrophic Factor; Cell Proliferation; Cell Survival; Cells, Cultured; Chronic Disease; Corticosterone; Depression; Hippocampus; Immunohistochemistry; L-Lactate Dehydrogenase; Male; Mice; Neurons; Piperidines; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Stem Cells; Stress, Psychological; Tetrazolium Salts; Thiazoles; Weight Gain | 2007 |
Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Eating; Female; Hyperphagia; Motor Activity; Olanzapine; Piperazines; Quinolones; Rats; Thiazoles; Weight Gain | 2008 |
Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
Topics: Abdominal Fat; Animals; Antipsychotic Agents; Benzodiazepines; Dietary Fats; Drinking Behavior; Feeding Behavior; Female; Injections, Intraperitoneal; Olanzapine; Piperazines; Rats; Risperidone; Thiazoles; Weight Gain | 2008 |
Ziprasidone in adolescents with autism: an open-label pilot study.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Child; Cholesterol; Dose-Response Relationship, Drug; Dystonia; Electrocardiography; Female; Humans; Male; Pilot Projects; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychometrics; Thiazoles; Treatment Outcome; Weight Gain | 2007 |
Developmental toxicity study in rats treated with the anticonvulsant, ralitoline.
Topics: Abnormalities, Drug-Induced; Animals; Anorexia; Anticonvulsants; Aorta, Thoracic; Ataxia; Bone and Bones; Dose-Response Relationship, Drug; Female; Fetal Growth Retardation; Fetal Resorption; Lethal Dose 50; Pregnancy; Pregnancy Complications; Rats; Rats, Sprague-Dawley; Seizures; Thiazoles; Weight Gain | 1995 |
L-2-oxothiazolidine-4-carboxylate, a cysteine precursor, stimulates growth and normalizes tissue glutathione concentrations in rats fed a sulfur amino acid-deficient diet.
Topics: Amino Acids, Sulfur; Animals; Bronchoalveolar Lavage Fluid; Diet; Glutathione; Growth; Liver; Lung; Lymphocytes; Male; Pyrrolidonecarboxylic Acid; Random Allocation; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidines; Weight Gain | 1995 |
Reproductive toxicology of the new antitussive moguisteine.
Topics: Abnormalities, Drug-Induced; Animals; Antitussive Agents; Embryo, Mammalian; Female; Fertility; Growth; Labor, Obstetric; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rabbits; Rats; Rats, Sprague-Dawley; Reproduction; Teratogens; Thiazoles; Thiazolidines; Weight Gain | 1994 |
Effect of troglitazone in type 2 diabetes mellitus.
Topics: Blood Glucose; Chromans; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Thiazoles; Thiazolidinediones; Troglitazone; Weight Gain | 1998 |
Significant weight gain with rezulin therapy.
Topics: Chromans; Diabetes Mellitus, Type 2; Edema; Humans; Hypoglycemic Agents; Male; Middle Aged; Thiazoles; Thiazolidinediones; Troglitazone; Weight Gain | 1999 |
Weight loss is often a problem in late PD.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Benzothiazoles; Drug Monitoring; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Thiazoles; Weight Gain | 1998 |
Mechanism of weight gain suppressing effect of ER-40133, an angiotensin I converting enzyme inhibitor, in growing rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Eating; Male; Neprilysin; Potassium; Rats; Rats, Sprague-Dawley; Sodium; Thiazoles; Weight Gain | 1999 |
The distribution of body mass index among individuals with and without schizophrenia.
Topics: Antipsychotic Agents; Body Mass Index; Clinical Trials as Topic; Comorbidity; Female; Health Surveys; Humans; Male; Obesity; Piperazines; Schizophrenia; Sex Factors; Thiazoles; United States; Weight Gain | 1999 |
Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism.
Topics: Animals; Biological Transport; Body Weight; Cell Line; Deoxyglucose; Glucose; In Vitro Techniques; Insulin; Ligands; Male; Muscle, Skeletal; Obesity; Oxazoles; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Thiazoles; Thiazolidinediones; Transcription Factors; Weight Gain | 1999 |
Antidiabetic activity of white skinned sweet potato (Ipomoea batatas L.) in obese Zucker fatty rats.
Topics: Animals; Blood Glucose; Chromans; Fatty Acids, Nonesterified; Glucose Tolerance Test; Hyperinsulinism; Hypoglycemic Agents; Insulin; Islets of Langerhans; Lactic Acid; Male; Plant Extracts; Rats; Rats, Zucker; Solanaceae; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone; Weight Gain | 2000 |
The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
Topics: 3T3 Cells; Adipose Tissue; Animals; Blood Glucose; Cell Differentiation; Chromans; Diabetes Mellitus, Type 2; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Oxadiazoles; Pioglitazone; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone; Weight Gain | 2000 |
Effects of advanced glycation end-product inhibition and cross-link breakage in diabetic rats.
Topics: Albuminuria; Animals; Collagen; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Drinking; Eye; Female; Glycation End Products, Advanced; Kidney; Organ Size; Phenazines; Radiopharmaceuticals; Rats; Rats, Wistar; Serum Albumin; Serum Albumin, Radio-Iodinated; Solubility; Tail; Tendons; Thiazoles; Weight Gain | 2000 |
[Are PPAR-gamma-agonists a secure choice in treatment of overweight diabetic patients?].
Topics: Chromans; Diabetes Mellitus; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Obesity; Thiazoles; Weight Gain | 2000 |
Aging and the neuroendocrine regulation of reproduction and body weight.
Topics: Aging; Animals; Arcuate Nucleus of Hypothalamus; Body Composition; Body Weight; Chromans; Eating; Gene Expression Regulation, Developmental; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hypoglycemic Agents; Insulin; Leptin; Male; Models, Animal; Neuropeptide Y; Neurosecretory Systems; Pituitary Gland; Rats; Rats, Inbred BN; Reproduction; RNA, Messenger; Testis; Thiazoles; Thiazolidinediones; Troglitazone; Weight Gain | 2000 |
Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adipose Tissue; Adrenal Glands; Adrenalectomy; Analysis of Variance; Animals; Blood Glucose; Corticosterone; Eating; Hydroxysteroid Dehydrogenases; Hypertrophy; Hypoglycemic Agents; Insulin; Liver; Male; Metformin; Obesity; Omentum; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Weight Gain | 2000 |
The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat.
Topics: Adipose Tissue, Brown; Animals; Body Weight; Carrier Proteins; Eating; Ion Channels; Membrane Proteins; Membrane Transport Proteins; Mitochondrial Proteins; Nicotinic Acids; Obesity; Proteins; Rats; Rats, Zucker; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Rosiglitazone; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Uncoupling Protein 1; Uncoupling Protein 2; Uncoupling Protein 3; Weight Gain | 2000 |
Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.
Topics: Adipocytes; Adipose Tissue; Analysis of Variance; Animals; Blood Glucose; Cell Division; Cell Size; DNA; Fatty Acids, Nonesterified; Feeding Behavior; Female; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Magnetic Resonance Imaging; Obesity; Pioglitazone; Rats; Rats, Zucker; Thiazoles; Thiazolidinediones; Thinness; Triglycerides; Weight Gain | 2001 |
Glitazones, glycemia, and global health status.
Topics: Blood Glucose; Health Status; Humans; Hypoglycemic Agents; Rosiglitazone; Thiazoles; Thiazolidinediones; Weight Gain | 2001 |
Troglitazone treatment of aging Brown Norway rats improves food intake and weight gain after fasting without increasing hypothalamic NPY gene expression.
Topics: Aging; Animals; Body Composition; Chromans; Eating; Fasting; Gene Expression; Hypoglycemic Agents; Hypothalamus; In Situ Hybridization; Insulin; Leptin; Male; Neuropeptide Y; Protein Precursors; Rats; Rats, Inbred BN; RNA, Messenger; Thiazoles; Thiazolidinediones; Troglitazone; Weight Gain | 2002 |
Blockade of body weight gain and plasma corticosterone levels in Zucker fatty rats using an orally active neuropeptide Y Y1 antagonist.
Topics: Adipose Tissue; Administration, Oral; Analysis of Variance; Animals; Appetite Depressants; Cell Size; Corticosterone; Eating; Male; Models, Animal; Morpholines; Obesity; Rats; Rats, Zucker; Receptors, Neuropeptide Y; Thiazoles; Weight Gain | 2002 |
[Exercising caution in choice of psychotropic drugs. Avoid drug-induced weight gain].
Topics: Antipsychotic Agents; Clinical Trials as Topic; Humans; Piperazines; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain | 2002 |
Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic.
Topics: Administration, Oral; Animals; Aspartate Aminotransferases; Cells, Cultured; Deferoxamine; Dihydropyridines; Dose-Response Relationship, Drug; Injections, Subcutaneous; Iodine Radioisotopes; Iron; Iron Chelating Agents; Iron Radioisotopes; Liver; Rats; Rats, Wistar; Thiazoles; Time Factors; Transferrin; Weight Gain | 1992 |
Methylthiazolidine-4-carboxylate for treatment of acute T-2 toxin exposure.
Topics: Animals; Antidotes; Drinking; Eating; Fasting; Glutathione; Liver; Male; Mice; Mice, Inbred ICR; Prodrugs; T-2 Toxin; Thiazoles; Weight Gain | 1991 |
[The subacute toxicity of glucosylthiazolidine-4-carbonic acid in rats].
Topics: Animals; Blood Cell Count; Blood Chemical Analysis; Dose-Response Relationship, Drug; Eating; Female; Glucosides; Kidney; Maillard Reaction; Male; Organ Size; Rats; Thiazoles; Urine; Weight Gain | 1990 |
L-2-oxothiazolidine-4-carboxylate as a cysteine precursor: efficacy for growth and hepatic glutathione synthesis in chicks and rats.
Topics: Administration, Oral; Animals; Chickens; Cysteine; Diet; Glutathione; Liver; Male; Pyrrolidonecarboxylic Acid; Random Allocation; Rats; Rats, Inbred Strains; Regression Analysis; Thiazoles; Thiazolidines; Weight Gain | 1990 |